Welcome to Gene Therapy

Muscles Everyone welcomes gene therapy to reduce muscle wasting and restore the debilitating muscle loss that the elderly brings. But what happens if you use the same treatment to improve your performance? Researchers developed a synthetic gene that prevents or even restores natural muscle degradation when injected into mouse muscle cells. This gene not only repairs muscle wasting and damage but also strengthens healthy muscle. This success tells human application. H. Sweeney of the University of Pennsylvania who commanded the study hopes that his findings will heal the real estate that plagues the elderly. However Sweeney 's troublesome mouse attracts the attention of athletes seeking competitive advantage. This treatment is not approved for use in humans, but the prospects for genetically engineered weight lifters, home run batters, line backers, and sprinters are easy to imagine.

Gene therapy uses DNA as a drug to treat diseases. Gene therapy was first conceptualized in 1972 and the authors urged attention before starting genetic studies on humans. The first FDA approved gene therapy trial in the US was held in 1990. She is a 4-year old girl named Ashanti DeSilva who received treatment for ADA-SCID. This is a disease that prevents her from fighting infection. W Dr. French Anderson is the principal investigator of clinical trials and works at the National Heart, Lung and Blood Laboratory. Since then, more than 1,700 clinical trials have been performed using a variety of gene therapy technologies.